نبذة مختصرة : Karcinom prostate je zloćudni tumor koji potječe od samih stanica prostate i jedan je od najvarijabilnijih tumora današnjice. Najčešće raste neprimjetno, ograničen samo na žlijezdu, međutim postoje i agresivniji tipovi. Agresivnost raka prostate mjerimo Gleason score ljestvicom nakon urađene biopsije. Metastaziraju upravo agresivni tumori i najčešća sijela su: kosti, pluća i jetra. To je 2. najčešći zloćudni tumor u Hrvatskoj. Najčešće obolijevaju muškarci od 70-74 godine. Rak prostate se najčešće liječi operativno, i to ukoliko nije metastazirao. Takva operacija se naziva radikalna prostatektomija, a oporavak je psihofizički iscrpljujući za pacijenta. Medicinske sestre imaju veliku ulogu u postoperativnom razdoblju kod pacijenata koji su bili na radikalnoj operaciji prostate. Osobe koje se tek susreću sa dijagnozom su u stanju šoka, potištene, često im padaju na pamet i suicidalne misli, u nevjerici su, nije im jasno zašto se to dogodilo baš njima, stoga skrb za pacijenta započinje već postavljanjem dijagnoze, a ne samo postoperativno. ; Prostate cancer is a malignant tumor that originates from the prostate cells themselves and is one of the most variable tumors today. Most often it grows imperceptibly, limited only to the gland, however there are also more aggressive types. The aggressiveness of prostate cancer is measured by the Gleason score scale after the biopsy. It is aggressive tumors that metastasize and the most common sites are: bones, lungs and liver. It is the 2nd most common malignant tumor in Croatia. Men aged 70-74 are most often affected. Prostate cancer is most often treated surgically, if it has not metastasized. Such an operation is called a radical prostatectomy, and recovery is psychologically and physically exhausting for the patient. Nurses play a major role in the postoperative period for patients who have undergone radical prostate surgery. People who are newly diagnosed are in a state of shock, depressed, suicidal thoughts often come to their mind, they are in disbelief, they don't ...
No Comments.